AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
SEQUENTIAL NEOADJUVANT CHEMOTHERAPY (SC) FOR HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC)
Authors: RIXE O GATINEAU M BATOUCHE M RAYMOND E DOMENGE C JANOT F SCHWAAB G LUBOINSKI B ARMAND JP
Citation: O. Rixe et al., SEQUENTIAL NEOADJUVANT CHEMOTHERAPY (SC) FOR HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC), Annals of oncology, 9, 1998, pp. 672-672
FULL-DOSE REIRRADIATION FOR UNRESECTABLE HEAD AND NECK-CARCINOMA - EXPERIENCE AT THE GUSTAVE-ROUSSY-INSTITUTE IN A SERIES OF 169 PATIENTS
Authors: DECREVOISIER R BOURHIS J DOMENGE C WIBAULT P KOSCIELNY S LUSINCHI A MAMELLE G JANOT F JULIERON M LERIDANT AM MARANDAS P ARMAND JP SCHWAAB G LUBOINSKI B ESCHWEGE F
Citation: R. Decrevoisier et al., FULL-DOSE REIRRADIATION FOR UNRESECTABLE HEAD AND NECK-CARCINOMA - EXPERIENCE AT THE GUSTAVE-ROUSSY-INSTITUTE IN A SERIES OF 169 PATIENTS, Journal of clinical oncology, 16(11), 1998, pp. 3556-3562
RED-BLOOD-CELL GLUTATHIONE LEVELS BEFORE AND DURING TREATMENT WITH NEOADJUVANT CHEMOTHERAPY CISPLATIN 5-FLUOROURACIL IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA/
Authors: MASSAADMASSADE L DOMENGE C RONGEAT S HASSOUN L LEGROS MH ROPERS J JANOT F PARISE O GOUYETTE A
Citation: L. Massaadmassade et al., RED-BLOOD-CELL GLUTATHIONE LEVELS BEFORE AND DURING TREATMENT WITH NEOADJUVANT CHEMOTHERAPY CISPLATIN 5-FLUOROURACIL IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA/, Anticancer research, 18(1A), 1998, pp. 283-288
AESTHESIONEUROBLASTOMA
Authors: KOKA VN JULIERON M BOURHIS J JANOT F LERIDANT AM MARANDAS P LUBOINSKI B SCHWAAB G
Citation: Vn. Koka et al., AESTHESIONEUROBLASTOMA, Journal of Laryngology and Otology, 112(7), 1998, pp. 628-633
COMBINED TRANSFACIAL AND NEUROSURGICAL APPROACH TO MALIGNANT-TUMORS OF THE ETHMOID SINUS
Authors: SALVAN D JULIERON M MARANDAS P JANOT F LERIDANT AM DOMENGE C MAMELLE G SCHWAAB G LUBOINSKI B
Citation: D. Salvan et al., COMBINED TRANSFACIAL AND NEUROSURGICAL APPROACH TO MALIGNANT-TUMORS OF THE ETHMOID SINUS, Journal of Laryngology and Otology, 112(5), 1998, pp. 446-450
LOSS OF C-ERB-B2 EXPRESSION AND TUMOR PROGRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC)
Authors: VIEGAS LC PARISE O TALBOT M KOWALSKI LP LUBOINSKI B JANOT F BOSQ J
Citation: Lc. Viegas et al., LOSS OF C-ERB-B2 EXPRESSION AND TUMOR PROGRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC), British Journal of Cancer, 77, 1998, pp. 127-127
ABSENCE OF C-ERB-B2 EXPRESSION AND RISK OF DISTANT METASTASIS IN PHARYNGEAL TUMORS
Authors: JANOT F GUERRY M VABRE L TALBOT M LERIDANT AM MAMELLE G HILL C BOSQ J LUBOINSKI B
Citation: F. Janot et al., ABSENCE OF C-ERB-B2 EXPRESSION AND RISK OF DISTANT METASTASIS IN PHARYNGEAL TUMORS, British Journal of Cancer, 77, 1998, pp. 128-128
RESECTION OF LUNG NEOPLASTIC NODULES LONG-TERM BENEFIT SURVIVAL FROM HEAD AND NECK-CANCER PATIENTS
Authors: DOMENGE C BATOUCHE M BELLAMY J DARTEVELLE P JANOT F MARANDAS P LUBOINSKI B
Citation: C. Domenge et al., RESECTION OF LUNG NEOPLASTIC NODULES LONG-TERM BENEFIT SURVIVAL FROM HEAD AND NECK-CANCER PATIENTS, British Journal of Cancer, 77, 1998, pp. 148-148
CHROMOSOME 11Q13 GENE AMPLIFICATIONS IN ORAL AND OROPHARYNGEAL CARCINOMAS - NO CORRELATION WITH SUBCLINICAL LYMPH-NODE INVASION AND DISEASERECURRENCE
Authors: FORTIN A GUERRY M GUERRY R TALBOT M PARISE O SCHWAAB G BOSQ J BOURHIS J SALVATORI P JANOT F BUSSON P
Citation: A. Fortin et al., CHROMOSOME 11Q13 GENE AMPLIFICATIONS IN ORAL AND OROPHARYNGEAL CARCINOMAS - NO CORRELATION WITH SUBCLINICAL LYMPH-NODE INVASION AND DISEASERECURRENCE, Clinical cancer research, 3(9), 1997, pp. 1609-1614
EPIDEMIOLOGY OF UPPER AERODIGESTIVE TRACT CANCER
Authors: SCHWAAB G JULIERON M JANOT F
Citation: G. Schwaab et al., EPIDEMIOLOGY OF UPPER AERODIGESTIVE TRACT CANCER, Neuro-chirurgie, 43(2), 1997, pp. 61-63
GENE-THERAPY FOR HEAD AND NECK-CANCER - COMPARING THE TUMOR-SUPPRESSOR GENE P53 AND A CELL-CYCLE REGULATOR WAF1 CIP1 (P21)/
Authors: CLAYMAN GL LIU TJ OVERHOLT SM MOBLEY SR WANG M JANOT F GOEPFERT H
Citation: Gl. Clayman et al., GENE-THERAPY FOR HEAD AND NECK-CANCER - COMPARING THE TUMOR-SUPPRESSOR GENE P53 AND A CELL-CYCLE REGULATOR WAF1 CIP1 (P21)/, Archives of otolaryngology, head & neck surgery, 122(5), 1996, pp. 489-493
INTENSIVE CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OFRADIOTHERAPY WITH CISPLATIN AND 7-WEEK CONTINUOUS INFUSIONAL FLUOROURACIL
Authors: WIBAULT P BENSMAINE MEA DEFORNI M ARMAND JP BERNAL ET GUILLOT T RECONDO G DOMENGE C JANOT F BOREL C LUBOINSKI B ESCHWEGE F CVITKOVIC E
Citation: P. Wibault et al., INTENSIVE CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OFRADIOTHERAPY WITH CISPLATIN AND 7-WEEK CONTINUOUS INFUSIONAL FLUOROURACIL, Journal of clinical oncology, 14(4), 1996, pp. 1192-1200
POTENTIAL DOUBLING TIME AND CLINICAL OUTCOME IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA TREATED WITH 70 GY IN 7 WEEKS
Authors: BOURHIS J DENDALE R HILL C BOSQ J JANOT F ATTAL P FORTIN A MARANDAS P SCHWAAB G WIBAULT P MALAISE EP BOBIN S LUBOINSKI B ESCHWEGE F WILSON G
Citation: J. Bourhis et al., POTENTIAL DOUBLING TIME AND CLINICAL OUTCOME IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA TREATED WITH 70 GY IN 7 WEEKS, International journal of radiation oncology, biology, physics, 35(3), 1996, pp. 471-476
NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN-VINDESINE-5-FLUOSOURACIL AND FOLINIC ACID FOR LOCALLY ADVANCED HEAD AND NECK-CARCINOMA
Authors: BENSMAINE MEA GUILLOT T BERNAL ET JANOT F SIGAL R DOMENGE C WIBAULT P ARMAND JP CVITKOVIC E
Citation: Mea. Bensmaine et al., NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN-VINDESINE-5-FLUOSOURACIL AND FOLINIC ACID FOR LOCALLY ADVANCED HEAD AND NECK-CARCINOMA, American journal of clinical oncology, 19(4), 1996, pp. 356-362
PROGNOSTIC VALUE OF CLINICOPATHOLOGICAL PARAMETERS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PROSPECTIVE ANALYSIS
Authors: JANOT F KLIJANIENKO J RUSSO A MAMET JP DEBRAUD F ELNAGGAR AK PIGNON JP LUBOINSKI B CVITKOVIC E
Citation: F. Janot et al., PROGNOSTIC VALUE OF CLINICOPATHOLOGICAL PARAMETERS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PROSPECTIVE ANALYSIS, British Journal of Cancer, 73(4), 1996, pp. 531-538
MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMASSENSITIVE OR RESISTANT TO CHEMOTHERAPY
Authors: RIBRAG V MASSAAD L JANOT F MORIZET J GOUYETTE A CHABOT GG
Citation: V. Ribrag et al., MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMASSENSITIVE OR RESISTANT TO CHEMOTHERAPY, Leukemia & lymphoma, 18(3-4), 1995, pp. 303-310
GLUTATHIONE SYSTEM AND CHEMORESPONSE TO 5-FLUOROURACIL AND CISPLATINEIN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PILOT-STUDY
Authors: DOMENGE C MASSADE L RONGEAT S HASSOUN L LEGROS MH JANOT F JULIERON M LUBOINSKI B GOUYETTE A
Citation: C. Domenge et al., GLUTATHIONE SYSTEM AND CHEMORESPONSE TO 5-FLUOROURACIL AND CISPLATINEIN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PILOT-STUDY, European journal of cancer, 31A, 1995, pp. 402-402
EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK IS ASSOCIATED WITH DEGREE OF HISTOLOGIC DIFFERENTIATION
Authors: JANOT F ELNAGGAR AK MORRISON RS LIU TJ TAYLOR DL CLAYMAN GL
Citation: F. Janot et al., EXPRESSION OF BASIC FIBROBLAST GROWTH-FACTOR IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK IS ASSOCIATED WITH DEGREE OF HISTOLOGIC DIFFERENTIATION, International journal of cancer, 64(2), 1995, pp. 117-123
TUMOR VASCULARIZATION, MITOTIC INDEX, HISTOPATHOLOGIC GRADE, AND DNA-PLOIDY IN THE ASSESSMENT OF 114 HEAD AND NECK SQUAMOUS-CELL CARCINOMAS
Authors: KLIJANIENKO J ELNAGGAR AK DEBRAUD F RODRIGUEZPERALTO JL RODRIGUEZ R ITZHAKI M RUSSO A JANOT F LUBOINSKI B CVITKOVIC E
Citation: J. Klijanienko et al., TUMOR VASCULARIZATION, MITOTIC INDEX, HISTOPATHOLOGIC GRADE, AND DNA-PLOIDY IN THE ASSESSMENT OF 114 HEAD AND NECK SQUAMOUS-CELL CARCINOMAS, Cancer, 75(7), 1995, pp. 1649-1656
THYMIDYLATE SYNTHASE ACTIVITY, FOLATES, AND GLUTATHIONE SYSTEM IN HEAD AND NECK-CARCINOMA AND ADJACENT TISSUES
Authors: PARISE O JANOT F LUBOINSKI B MASSAAD L ALBIN N TOUSSAINT C VERJUS MA BONNAY M GOUYETTE A CHABOT GG
Citation: O. Parise et al., THYMIDYLATE SYNTHASE ACTIVITY, FOLATES, AND GLUTATHIONE SYSTEM IN HEAD AND NECK-CARCINOMA AND ADJACENT TISSUES, Head & neck, 16(2), 1994, pp. 158-164
CHROMOSOME-11Q13 GENE AMPLIFICATIONS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - RELATION WITH LYMPH-NODE INVASION
Authors: PARISE O JANOT F GUERRY R FORTIN A LUBOINSKI B TURSZ T SCHWAAB G BUSSON P
Citation: O. Parise et al., CHROMOSOME-11Q13 GENE AMPLIFICATIONS IN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS - RELATION WITH LYMPH-NODE INVASION, International journal of oncology, 5(2), 1994, pp. 309-313
IN-VITRO PARAMETERS AND TREATMENT OUTCOME IN HEAD AND NECK CANCERS TREATED WITH SURGERY AND OR RADIATION - CELL CHARACTERIZATION AND CORRELATIONS WITH LOCAL-CONTROL AND OVERALL SURVIVAL/
Authors: GIRINSKY T BERNHEIM A LUBIN R TAVAKOLIRAZAVI T BAKER F JANOT F WIBAULT P COSSET JM DUVILLARD P DUVERGER A FERTIL B
Citation: T. Girinsky et al., IN-VITRO PARAMETERS AND TREATMENT OUTCOME IN HEAD AND NECK CANCERS TREATED WITH SURGERY AND OR RADIATION - CELL CHARACTERIZATION AND CORRELATIONS WITH LOCAL-CONTROL AND OVERALL SURVIVAL/, International journal of radiation oncology, biology, physics, 30(4), 1994, pp. 789-794
PRINCIPAL DRUG-METABOLIZING ENZYME-SYSTEMS IN L1210 LEUKEMIA SENSITIVE OR RESISTANT TO BCNU IN-VIVO
Authors: RIBRAG V MASSAAD L JANOT F BISSERY MC PARISE O GOUYETTE A CHABOT GG
Citation: V. Ribrag et al., PRINCIPAL DRUG-METABOLIZING ENZYME-SYSTEMS IN L1210 LEUKEMIA SENSITIVE OR RESISTANT TO BCNU IN-VIVO, Leukemia research, 18(11), 1994, pp. 829-835
ETHMOID SINUS CARCINOMAS - RESULTS AND PROGNOSIS AFTER NEOADJUVANT CHEMOTHERAPY AND COMBINED SURGERY - A 10-YEAR EXPERIENCE
Authors: ROUX FX BRASNU D DEVAUX B CHABARDES E SCHWAAB G LACCOURREYE O MENARD M JANOT F NGUYEN S BERTRAND J MEDER JF
Citation: Fx. Roux et al., ETHMOID SINUS CARCINOMAS - RESULTS AND PROGNOSIS AFTER NEOADJUVANT CHEMOTHERAPY AND COMBINED SURGERY - A 10-YEAR EXPERIENCE, Surgical neurology, 42(2), 1994, pp. 98-104
RAPID TUMOR-CELL PROLIFERATION AFTER INDUCTION CHEMOTHERAPY IN OROPHARYNGEAL CANCER
Authors: BOURHIS J WILSON G WIBAULT P BOSQ J ARMAND JP LUBOINSKI B MALAISE EP ESCHWEGE F JANOT F
Citation: J. Bourhis et al., RAPID TUMOR-CELL PROLIFERATION AFTER INDUCTION CHEMOTHERAPY IN OROPHARYNGEAL CANCER, The Laryngoscope, 104(4), 1994, pp. 468-472
Risultati: 1-25 | 26-31